Metformin-treated patients with diabetes showed a lower risk of intrahepatic cholangiocarcinoma compared with diabetes patients not taking the drug, researchers reported in Hepatology. Biliary tract disease, cirrhosis, diabetes and smoking were associated with an increased risk of ICC onset, researchers noted.
Lower ICC risk seen in diabetes patients on metformin
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|NGS Provider Enrollment Rep||
National Government Services - WellPoint
|Program Manager II||
Tufts Health Plan/Network Health
|Director, Medicare Advantage/Medicare Part D Focus||
|Director of Clinical Research||
Regenesis Biomedical, Inc.